Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3822610
Max Phase: Preclinical
Molecular Formula: C20H21N5O3S
Molecular Weight: 411.49
Molecule Type: Small molecule
Associated Items:
ID: ALA3822610
Max Phase: Preclinical
Molecular Formula: C20H21N5O3S
Molecular Weight: 411.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(C(=O)N2CCN(C)CC2)ccc1NC(=O)c1csc2cncnc12
Standard InChI: InChI=1S/C20H21N5O3S/c1-24-5-7-25(8-6-24)20(27)13-3-4-15(16(9-13)28-2)23-19(26)14-11-29-17-10-21-12-22-18(14)17/h3-4,9-12H,5-8H2,1-2H3,(H,23,26)
Standard InChI Key: IKFWNJULDLDZTG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 411.49 | Molecular Weight (Monoisotopic): 411.1365 | AlogP: 2.34 | #Rotatable Bonds: 4 |
Polar Surface Area: 87.66 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.21 | CX Basic pKa: 6.83 | CX LogP: 1.39 | CX LogD: 1.29 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.71 | Np Likeness Score: -1.93 |
1. Muraoka T, Ide M, Morikami K, Irie M, Nakamura M, Miura T, Kamikawa T, Nishihara M, Kashiwagi H.. (2016) Discovery of a potent and highly selective transforming growth factor β receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD)., 24 (18): [PMID:27448772] [10.1016/j.bmc.2016.07.006] |
Source(1):